Healionics Corporation, a developer of synthetic biomaterial-based medical devices, announced recently that 24-month clinical ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

Please provide your email address to receive an email when new articles are posted on . Researchers found one-fifth of surgeons diverged from recommended best practice guidelines by using an ...

A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...

The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis. Among permanent ...

Establishing and maintaining adequate vascular access is essential to providing an appropriate dialysis dose in patients with end-stage renal disease. Complications related to vascular access have a ...

April 23, 2009 — Five of 10 autologous tissue-engineered vascular grafts, implanted as arteriovenous shunts for hemodialysis access in patients with end-stage renal disease, continued to function ...

Using a stent graft to keep open failing arteriovenous dialysis grafts results in better patency and fewer reinterventions than angioplasty alone. Twelve-month results of the RENOVA trial were ...

NEW ORLEANS—Stent grafts are more effective than balloon angioplasty in establishing and maintaining patency of collapsed dialysis access grafts, according to researchers. Data presented at the ...

At 24 months, the target lesion primary patency (TLPP) 1 was 41.7% At 24 months, the access circuit primary patency (ACPP) 2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit ...

May 20, 2009 — Treatment with dipyridamole plus aspirin improves hemodialysis graft patency, according to the results of a randomized, double-blind, placebo-controlled trial reported in the May 21 ...